Advertisement
Screener

XENON PHARMACEUTICALS INC. (XENE) Pre-Tax Margin

Xenon Pharmaceuticals Inc. Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Xenon Pharmaceuticals Inc. pre-tax margin for the quarter ending 2025-03-31 was -861.60%.
  • Xenon Pharmaceuticals Inc. pre-tax margin for the quarter ending 2022-09-30 was -28588.64%, a change of -28396.00% year-over-year.
  • Xenon Pharmaceuticals Inc. pre-tax margin for the quarter ending 2022-06-30 was -5820.52%, a change of -4813.94% year-over-year.
  • Xenon Pharmaceuticals Inc. pre-tax margin for the quarter ending 2022-03-31 was -228.88%, a change of 134.40% year-over-year.
  • Xenon Pharmaceuticals Inc. pre-tax margin for fiscal 2025 was -4598.59%.
  • Xenon Pharmaceuticals Inc. pre-tax margin for fiscal 2022 was -1327.70%, a change of -899.82% from fiscal 2021.
  • Xenon Pharmaceuticals Inc. pre-tax margin for fiscal 2021 was -427.88%, a change of -337.43% from fiscal 2020.
  • Xenon Pharmaceuticals Inc. pre-tax margin for fiscal 2020 was -90.45%, a change of 518.98% from fiscal 2019.
Available history
2019-09-30 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-03-31-861.60%-$64.62M$7.5M
2022-09-30-28588.64%-$37.74M$132,000.00
2022-06-30-5820.52%-$31.2M$536,000.00
2022-03-31-228.88%-$20.06M$8.77M
2021-12-31-671.13%-$25.08M$3.74M
2021-09-30-192.64%-$15.65M$8.12M
2021-06-30-1006.58%-$22.33M$2.22M
2021-03-31-363.29%-$15.83M$4.36M
2020-12-31-239.55%-$12.34M$5.15M
2020-09-30-138.21%-$9.06M$6.55M
2020-06-30-1.60%-$214,000.00$13.38M
2020-03-31-105.75%-$7.49M$7.08M
2019-12-31-342.81%-$11.41M$3.33M
2019-09-30-253.31%-$8.87M$3.5M

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-12-31-4598.59%-$344.89M$7.5M
2022-12-31-1327.70%-$125.26M$9.43M
2021-12-31-427.88%-$78.89M$18.44M
2020-12-31-90.45%-$29.09M$32.17M
2019-12-31-609.43%-$41.62M$6.83M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Organon & Co. (OGN)United States$3.603B17.03
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09